001     132443
005     20240229111722.0
024 7 _ |a 10.1038/nm.4452
|2 doi
024 7 _ |a pmid:29227474
|2 pmid
024 7 _ |a 1078-8956
|2 ISSN
024 7 _ |a 1546-170X
|2 ISSN
024 7 _ |a altmetric:30293366
|2 altmetric
037 _ _ |a DKFZ-2018-00131
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Lehmann, Lorenz H
|b 0
245 _ _ |a A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway.
260 _ _ |a New York, NY
|c 2018
|b Nature America Inc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1550485774_632
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The stress-responsive epigenetic repressor histone deacetylase 4 (HDAC4) regulates cardiac gene expression. Here we show that the levels of an N-terminal proteolytically derived fragment of HDAC4, termed HDAC4-NT, are lower in failing mouse hearts than in healthy control hearts. Virus-mediated transfer of the portion of the Hdac4 gene encoding HDAC4-NT into the mouse myocardium protected the heart from remodeling and failure; this was associated with decreased expression of Nr4a1, which encodes a nuclear orphan receptor, and decreased NR4A1-dependent activation of the hexosamine biosynthetic pathway (HBP). Conversely, exercise enhanced HDAC4-NT levels, and mice with a cardiomyocyte-specific deletion of Hdac4 show reduced exercise capacity, which was characterized by cardiac fatigue and increased expression of Nr4a1. Mechanistically, we found that NR4A1 negatively regulated contractile function in a manner that depended on the HBP and the calcium sensor STIM1. Our work describes a new regulatory axis in which epigenetic regulation of a metabolic pathway affects calcium handling. Activation of this axis during intermittent physiological stress promotes cardiac function, whereas its impairment in sustained pathological cardiac stress leads to heart failure.
536 _ _ |a 322 - Genetics and Pathophysiology (POF3-322)
|0 G:(DE-HGF)POF3-322
|c POF3-322
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Jebessa, Zegeye H
|b 1
700 1 _ |a Kreusser, Michael M
|b 2
700 1 _ |a Horsch, Axel
|b 3
700 1 _ |a He, Tao
|b 4
700 1 _ |a Kronlage, Mariya
|b 5
700 1 _ |a Dewenter, Matthias
|b 6
700 1 _ |a Sramek, Viviana
|b 7
700 1 _ |a Oehl, Ulrike
|b 8
700 1 _ |a Krebs-Haupenthal, Jutta
|b 9
700 1 _ |a von der Lieth, Albert H
|b 10
700 1 _ |a Schmidt, Andrea
|b 11
700 1 _ |a Sun, Qiang
|b 12
700 1 _ |a Ritterhoff, Julia
|b 13
700 1 _ |a Finke, Daniel
|b 14
700 1 _ |a Völkers, Mirko
|b 15
700 1 _ |a Jungmann, Andreas
|b 16
700 1 _ |a Sauer, Sven W
|b 17
700 1 _ |a Thiel, Christian
|b 18
700 1 _ |a Nickel, Alexander
|b 19
700 1 _ |a Kohlhaas, Michael
|b 20
700 1 _ |a Schäfer, Michaela
|b 21
700 1 _ |a Sticht, Carsten
|b 22
700 1 _ |a Maack, Christoph
|b 23
700 1 _ |a Gretz, Norbert
|b 24
700 1 _ |a Wagner, Michael
|b 25
700 1 _ |a El-Armouche, Ali
|b 26
700 1 _ |a Maier, Lars S
|b 27
700 1 _ |a Londoño, Juan E Camacho
|b 28
700 1 _ |a Meder, Benjamin
|b 29
700 1 _ |a Freichel, Marc
|b 30
700 1 _ |a Gröne, Hermann-Josef
|0 P:(DE-He78)00a2ea610aee4a8fca32908fc3d02e91
|b 31
|u dkfz
700 1 _ |a Most, Patrick
|b 32
700 1 _ |a Müller, Oliver J
|0 0000-0001-8223-2638
|b 33
700 1 _ |a Herzig, Stephan
|0 P:(DE-He78)e527f794b23172e769c8904180546f57
|b 34
|u dkfz
700 1 _ |a Furlong, Eileen E M
|0 0000-0002-9544-8339
|b 35
700 1 _ |a Katus, Hugo A
|b 36
700 1 _ |a Backs, Johannes
|0 0000-0002-2322-2699
|b 37
773 _ _ |a 10.1038/nm.4452
|g Vol. 24, no. 1, p. 62 - 72
|0 PERI:(DE-600)1484517-9
|n 1
|p 62 - 72
|t Nature medicine
|v 24
|y 2018
|x 1546-170X
909 C O |p VDB
|o oai:inrepo02.dkfz.de:132443
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 31
|6 P:(DE-He78)00a2ea610aee4a8fca32908fc3d02e91
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 34
|6 P:(DE-He78)e527f794b23172e769c8904180546f57
913 1 _ |a DE-HGF
|l Herz-Kreislauf-Stoffwechselerkrankungen
|1 G:(DE-HGF)POF3-320
|0 G:(DE-HGF)POF3-322
|2 G:(DE-HGF)POF3-300
|v Genetics and Pathophysiology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT MED : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b NAT MED : 2015
920 1 _ |0 I:(DE-He78)G130-20160331
|k G130
|l Zelluläre und Molekulare Pathologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G130-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21